These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3912192)

  • 1. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man.
    Edsbäcker S; Andersson KE; Ryrfeldt A
    Eur J Clin Pharmacol; 1985; 29(4):477-81. PubMed ID: 3912192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of the epimeric glucocorticoid budesonide.
    Ryrfeldt A; Edsbäcker S; Pauwels R
    Clin Pharmacol Ther; 1984 Apr; 35(4):525-30. PubMed ID: 6705451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
    Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
    Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic effects of two nasally administered glucocorticosteroids.
    Wihl JA; Andersson KE; Johansson SA
    Allergy; 1997 Jun; 52(6):620-6. PubMed ID: 9226055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide inhibits plasma extravasation induced by capsaicin and by substance P in the rat nasal mucosa.
    Bacci E; Bertrand C; Geppetti P; Baker J; Nadel JA; Laitinen LA; Petersson G
    Regul Pept; 1993 Dec; 49(2):159-66. PubMed ID: 7510897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis.
    Day J; Alexander M; Drouin M; Frankish C; Mazza J; Moote W; Patel P; Ramsdale H; Yang W
    Am J Rhinol; 1997; 11(1):77-83. PubMed ID: 9065352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide.
    Knutsson PU; Brönnegård M; Marcus C; Stierna P
    J Allergy Clin Immunol; 1996 Feb; 97(2):655-61. PubMed ID: 8621851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man.
    Johansson SA; Andersson KE; Brattsand R; Gruvstad E; Hedner P
    Eur J Clin Pharmacol; 1982; 22(6):523-9. PubMed ID: 7128664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide and nasal histamine challenge.
    Pipkorn U
    Allergy; 1982 Jul; 37(5):359-63. PubMed ID: 7125153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
    Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
    Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.
    Chanoine F; Grenot C; Heidmann P; Junien JL
    Drug Metab Dispos; 1991; 19(2):546-53. PubMed ID: 1676668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with budesonide in vasomotor rhinitis.
    Pipkorn U; Berge T
    Acta Otolaryngol; 1983; 95(1-2):167-71. PubMed ID: 6829298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a topical glucocorticoid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique.
    Bende M; Lindqvist N; Pipkorn U
    Allergy; 1983 Oct; 38(7):461-4. PubMed ID: 6356965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man.
    Johansson SA; Andersson KE; Brattsand R; Gruvstad E; Hedner P
    Eur J Respir Dis Suppl; 1982; 122():74-82. PubMed ID: 6958496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nasal mucosa and systemic repercussion of the topical and prolonged use of budesonide in patients with perennial allergic rhinitis].
    López Aguado D; López Campos D; García González LA; Pérez Piñero B; Campos Bañales ME
    Acta Otorrinolaringol Esp; 2000; 51(8):709-12. PubMed ID: 11270106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal budesonide for the treatment of perennial rhinitis in Thai patients.
    Bunnag C; Dhorranintra B; Jareoncharsri P
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):116-20. PubMed ID: 3219158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact dermatitis from budesonide in a nasal spray without cross-reactivity to amcinonide.
    Gamboa PM; Jáuregui I; Antépara I
    Contact Dermatitis; 1991 Mar; 24(3):227-8. PubMed ID: 1831101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma cortisol level, hematocrit and hemoglobin value as well as erythrocyte count and differential blood picture in twice-daily budesonide inhalation therapy].
    Zimmermann I; Ulmer WT
    Prax Klin Pneumol; 1984 Nov; 38(11):506-9. PubMed ID: 6514676
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasally administered budesonide, a glucocorticoid, does not exert its clinical effect through vasoconstriction.
    Lindqvist N; Holmberg K; Pipkorn U
    Clin Otolaryngol Allied Sci; 1989 Dec; 14(6):519-23. PubMed ID: 2692883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis. A 12-month multicentre study.
    Lindqvist N; Balle VH; Karma P; Kärjä J; Lindström D; Mäkinen J; Pukander J; Ruoppi P; Suonpää J; Ostlund W
    Allergy; 1986 Apr; 41(3):179-86. PubMed ID: 3521382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.